Thalassemia Clinical Research Network (TCRN)
WHO WE ARE

The Thalassemia Clinical Research Network (TCRN) was founded in 1998 by the National Heart Lung and Blood Institute (NHLBI), part of the National Institute of Health (NIH), to provide a national structure to conduct clinical studies in thalassemia.

The TCRN has been successfully funded for two, five-year cycles by the NHLBI based on the success of our studies. The five main centers involved with the TCRN in North America are Children's Hospital & Research Center at Oakland, Children’s Hospital Boston, Toronto General Hospital, Weill Medical College of Cornell University and Children’s Hospital Philadelphia. There are also numerous satellite sites around the country. The TCRN has even expanded recently to include sites in London, England and Beirut, Lebanon.

Here at Children's Hospital & Research Center at Oakland, we collaborate with other centers around California and Canada, to provide comprehensive clinical and research care to patients with thalassemia in as broad of an area as possible. The satellites we work with include: Children’s Hospital Central California in Madera, University of California, San Francisco, Children’s Hospital Los Angeles, Lucile Packard Children’s Hospital at Stanford, Children’s Hospital Orange County, University of California Davis and British Columbia Children’s Hospital.